Doping: Shaw ban raises questions for India
NEW DELHI: India’s powerful cricket board is under pressure to bring its anti-doping procedures into line with world standards after questions were raised over the ban handed to teenage star Prithvi Shaw.
Shaw, the 19-year-old prodigy often compared to Sachin Tendulkar, last week received an eight-month ban after the Board of Control for Cricket in India ruled he “inadvertently ingested a prohibited substance (terbutaline), which can commonly be found in cough syrups”.
Shaw’s ban was backdated to March 16, despite the fact he was playing for the Delhi Capitals in the Indian Premier League until May 8. He will be available again from November 16, just after the start of India’s international season.
The BCCI insists on handling its doping analysis and sanctions in-house, rebuffing pressure from India’s government and the World Anti-Doping Agency to come under the ambit of India’s WADA-accredited national anti-doping body.
However, concern is growing about the arrangements, with many calling for more rigorous testing by an independent body.Last year, Indian all-rounder Yusuf Pathan also tested positive for terbutaline and received a backdated ban after the BCCI accepted he took it “inadvertently”, offering the same explanation that the drug is often found in cough syrups.